← brief for 2026-10-07 · Slowing decline

Sartans and Bisartans: Expanding Therapeutic Horizons Through Broad Receptor Interactions and Repurposing Potential

Key takeaways

This review looks at how blood pressure drugs called sartans work. It uses computer models to show these drugs may affect more than one type of body receptor. This is a computer-based study, not a test in people. It suggests these drugs might have new uses, but we need human trials to prove it.

Who did this work

Errikos Petsas (National and Kapodistrian University of Athens) · Vasso Apostolopoulos (RMIT University) · Despoina P. Kiouri (National and Kapodistrian University of Athens) · Konstantinos Kelaidonis · Harry F. Ridgway (Victoria University) · Graham J. Moore · Thomas Mavromoustakos (National and Kapodistrian University of Athens) · Laura Kate Gadanec (Victoria University) · John Matsoukas (University of Calgary) · Christos T. Chasapis (National and Kapodistrian University of Athens)

Source

Article · OpenAlex, CKD works · 2026-10-06
https://doi.org/10.3390/ijms27198883